Our latest thinking

Arcadia (arcadia.io), the leading data analytics platform for healthcare, announced today that it has earned inclusion in Built In’s 100 Best Places to Work in 2023. The emphasis on culture, diversity, and inclusiveness at Arcadia contributed to its overall rankings of No. 39 in Boston and No. 56 in Chicago. Arcadia also received recognition in the category of Best Midsize Companies to Work for; No. 19 in Boston and No. 27 in Chicago.

Arcadia was included in the annual Inc. 5000 list, Boston Business Journal 2022 Fast 50 honorees, and 100 Best Places to Work In Boston.

D’Arcy will prioritize nurturing the company’s culture, and recruiting and retaining the healthcare technology industry’s top talent.

KLAS recognized the successful payer, provider, and vendor collaborations that reduce cost and inefficiency and deliver a better patient experience.

Arcadia’s longstanding commitment to security includes achieving formal certifications (ISO 27001, SOC 2) and building an organizational culture that places security at the center of every decision. Now, Arcadia has been recognized for our cybersecurity transparency with a new award from KLAS and Censinet.

Leveraging Arcadia’s population health management platform, Rush Health has united four hospitals, 140 practices and 2,300 providers and implemented a quality improvement program that has enhanced care and financial value through better performance in fee-for-value payment models covering more than 150,000 patients. In 2020, Rush Health’s ACO delivered Medicare cost savings of $19.8 million, earned $9.6 million in shared savings, and achieved a quality score of 97%.

Arcadia was awarded the 2022 Best in KLAS designation for Value-Based Care Managed Services with a score of 88.2, marking the fourth consecutive year that Arcadia has earned the award.

The key finding of the analysis is that COVID patients had a high mortality rate post-discharge compared to the general population — and a mortality rate even higher than discharged patients who had a diagnosis of sepsis.

Arcadia’s new study, published on medRxiv, shows that current vaccines reduce the risk of long-COVID, even when administered up to 12 weeks after a COVID diagnosis.

We helped our national network of ACOs generate more than $386 million in the 2020 Medicare Shared Savings Program (MSSP) using Arcadia Analytics.